| Ident. | Authors (with country if any) | Title |
|---|
| 000C76 (2011) |
RUIQIZHANG [République populaire de Chine] ; XIA RONG [République populaire de Chine] ; WEIQI PAN [République populaire de Chine] ; TAO PENG [République populaire de Chine] | Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1 |
| 000C97 (2011) |
ZHONGPENG ZHAO [République populaire de Chine] ; FANG YAN [République populaire de Chine] ; ZHONGWEI CHEN [République populaire de Chine] ; DEYAN LUO [République populaire de Chine] ; YUEQIANG DUAN [République populaire de Chine] ; PENGHUI YANG [République populaire de Chine] ; ZHONGLI [République populaire de Chine] ; DAXIN PENG [République populaire de Chine] ; Xiufan Liy [République populaire de Chine] ; XILIANG WANG [République populaire de Chine] | Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab')2 against highly pathogenic avian influenza H5N1 in mice |
| 000D06 (2011) |
Thanyada Rungrotmongkol [Thaïlande] ; Pathumwadee Yotmanee [Thaïlande] ; Nadtanet Nunthaboot [Thaïlande] ; Supot Hannongbua [Thaïlande] | Computational Studies of Influenza A Virus at Three Important Targets: Hemagglutinin, Neuraminidase and M2 Protein |
| 000E06 (2011) |
DUJUAN LI [République populaire de Chine, États-Unis] ; JIANPING WANG [République populaire de Chine] ; RONGHUI WANG [États-Unis] ; YANBIN LI [États-Unis] ; Daad Abi-Ghanem [États-Unis] ; Luc Berghman [États-Unis] ; Billy Hargis [États-Unis] ; HUAGUANG LU [États-Unis] | A nanobeads amplified QCM immunosensor for the detection of avian influenza virus H5N1 |
| 001094 (2010) |
James R. Smith [Suisse] | Oseltamivir in human avian influenza infection |
| 001095 (2010) |
Nicolas Widmer [Suisse] ; Pascal Meylan [Suisse] ; Anton Ivanyuk [Suisse] ; Manel Aouri [Suisse] ; Laurent A. Decosterd [Suisse] ; Thierry Buclin [Suisse] | Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics |
| 001119 (2010) |
Janina Geiler [Allemagne] ; Martin Michaelis [Allemagne] ; Patrizia Naczk [Allemagne] ; Anke Leutz [Allemagne] ; Klaus Langer [Allemagne] ; Hans-Wilhelm Doerr [Allemagne] ; Jindrich Jr Cinatl [Allemagne] | N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus |
| 001345 (2010) |
Michael J. Loeffelholz [États-Unis] | Avian Influenza A H5N1 Virus |
| 001353 (2010) |
Tomoko Morimoto [Japon] ; Hirofumi Ishikawa [Japon] | Assessment of intervention strategies against a novel influenza epidemic using an individual-based model |
| 001365 (2010) |
D. Ramjeesingh [Jamaïque] ; A. S. Wright [Jamaïque] ; H. Mcdavid [Jamaïque] | An Intense Influenza Pandemic - Possible Subtype of H5N1 Its Implications for Jamaica |
| 001380 (2010) |
Saori Sakabe [Japon] ; Kiyoko Iwatsuki-Horimoto [Japon] ; Taisuke Horimoto [Japon] ; Chairul A. Nidom [Indonésie] ; Mai Thi Quynh Le [Viêt Nam] ; Ryo Takano [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshinobu Okuno [Japon] ; Makoto Ozawa [Japon, États-Unis] ; Yoshihiro Kawaoka [Japon, États-Unis] | A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1 N1 ) 2009 virus infection |
| 001384 (2010) |
Jiri Beran [République tchèque] ; Ibrahim A. Abdel-Messih [Italie] ; Jolana Raupachova [République tchèque] ; Lenka Hobzova [République tchèque] ; Elena Fragapane [Italie] | A Phase III, Randomized, Open-Label Study to Assess the Tolerability and Immunogenicity of an H5N1 Influenza Vaccine Administered to Healthy Adults With a 1-, 2-, 3-, or 6-Week Interval Between First and Second Doses |
| 001436 (2009) |
A. Minchella [France] ; O. Onde [France] ; E. Vernes [France] ; G. Perrat [France] ; J. De La Coussaye [France] ; A. Sotto [France] | Évaluation de la préparation à une pandémie grippale par un exercice de terrain au centre hospitalier universitaire de Nîmes |
| 001455 (2009) |
M. Bouscambert-Duchamp [France] ; B. Lina [France] ; F. Morfin [France] | Grippe aviaire chez l'enfant |
| 001496 (2009) |
Elena A. Govorkova [États-Unis] ; Natalia A. Ilyushina [États-Unis, Russie] ; Jennifer L. Mcclaren [États-Unis] ; Tri S. P. Naipospos [Indonésie] ; Bounlom Douangngeun [Laos] ; Robert G. Webster [États-Unis] | Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse Model |
| 001540 (2009) |
Nayana Prabhu [Singapour] ; Mookkan Prabakaran [Singapour] ; QIAN HONGLIANG [Singapour] ; FANG HE [Singapour] ; Hui-Ting Ho [Singapour] ; JIA QIANG [Singapour] ; Michael Goutama [Singapour] ; Angeline Pei-Chiew Pei-Chiew Lim [Singapour] ; Brendon J. Hanson [Singapour] ; Jimmy Kwang [Singapour] | Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza |
| 001551 (2009) |
Neal Van Hoeven [États-Unis] ; Jessica A. Belser [États-Unis] ; Kristy J. Szretter [États-Unis] ; HUI ZENG [États-Unis] ; Peter Staeheli [Allemagne] ; David E. Swayne [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Terrence M. Tumpey [États-Unis] | Pathogenesis of 1918 Pandemic and H5N1 Influenza Virus Infections in a Guinea Pig Model : Antiviral Potential of Exogenous Alpha Interferon To Reduce Virus Shedding |
| 001584 (2009) |
Aeron C. Hurt [Australie] ; Jessica K. Holien [Australie] ; Michael W. Parker [Australie] ; Ian G. Barr [Australie] | Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses |
| 001640 (2009) |
JIANG WU [République populaire de Chine] ; Han-Hua Fang [République populaire de Chine] ; Jiang-Ting Chen [République populaire de Chine] ; Ji-Chen Zhou [République populaire de Chine] ; Zi-Jian Feng [République populaire de Chine] ; Chang-Gui Li [République populaire de Chine] ; Yuan-Zheng Qiu [République populaire de Chine] ; YAN LIU [République populaire de Chine] ; MIN LU [République populaire de Chine] ; Li-Ying Liu [République populaire de Chine] ; Shan-Shan Dong [République populaire de Chine] ; QIANG GAO [République populaire de Chine] ; Xiao-Mei Zhang [République populaire de Chine] ; NAN WANG [République populaire de Chine] ; Wei-Dong Yin [République populaire de Chine] ; Xiao-Ping Dong [République populaire de Chine] | Immunogenicity, Safety, and Cross-Reactivity of an Inactivated, Adjuvanted, Prototype Pandemic Influenza (H5N1) Vaccine : A Phase II, Double-Blind, Randomized Trial |
| 001643 (2009) |
Lamberto Manzoli [Italie] ; Georgia Salanti [Grèce] ; Corrado De Vito [Italie] ; Antonio Boccia [Italie] ; John P. A. Loannidis [Grèce, États-Unis] ; Paolo Villari [Italie] | Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis |
| 001676 (2009) |
Janette Taylor [Australie] ; Kenneth Mcphie [Australie] ; Julian Druce [Australie] ; Chris Birch [Australie] ; Dominic E. Dwyer [Australie] | Evaluation of Twenty Rapid Antigen Tests for the Detection of Human Influenza A H5N1, H3N2, H1N1, and B Viruses |
